Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia

doi:10.1084/jem.163.2.347

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Uckun, F. M.
	Articles by Vallera, D. A.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Uckun, F. M.
	Articles by Vallera, D. A.


Social Bookmarking

	What's this?

ARTICLES

Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia

FM Uckun, KJ Gajl-Peczalska, JH Kersey, LL Houston and DA Vallera

We report a novel colony assay for B-lineage progenitor cells in acute lymphoblastic leukemia (ALL). The primary plating efficiency of blast progenitors freshly obtained from common B-lineage ALL patients varied between 0.09 and 2.63%. Morphological, cytochemical, and immunological analyses of cells from day 7 colonies provided the evidence that they are B-lineage lymphoblasts. Immunological marker analyses of cultured blasts using BA-2 (anti-CD9), BA-3 (anti-CD10), BA-1 (anti-CD24), and B43 mAb have allowed us to define two distinct immunological groups. The first group had BA-2+, BA-3+, BA-1+, B43+ marker profiles, consistent with the phenotype of uncultured bone marrow blasts. The second group differed in that the cells in the blast colonies were BA-3 (anti-CD10)-negative, although many of the cells in the bulk population were BA-3+ before culture. Blasts from both groups were able to proliferate and form secondary colonies when recultured. A pan-B immunotoxin was synthesized by linking B43, a human B cell-specific mAb, to pokeweed antiviral protein (PAP). This study showed that B43- PAP can effectively eradicate leukemic progenitor cells freshly obtained from patients with common B-lineage ALL. B43-PAP eliminated greater than 99.96% of blast progenitors under conditions in which only minimal inhibition of normal bone marrow progenitor cells (CFU-GM, CFU- E, CFU-MK, CFU-GEMM) was observed. Our results establish that the surface determinant recognized by B43 is expressed on B-lineage progenitor cells in ALL, and that these cells are sensitive to PAP at the ribosomal level. To our knowledge, B43-PAP is the first IT to prove effective against common B-lineage ALL cells.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Vallera, D. A., Todhunter, D. A., Kuroki, D. W., Shu, Y., Sicheneder, A., Chen, H. (2005). A Bispecific Recombinant Immunotoxin, DT2219, Targeting Human CD19 and CD22 Receptors in a Mouse Xenograft Model of B-Cell Leukemia/Lymphoma. Clin. Cancer Res. 11: 3879-3888 [Abstract] [Full Text]
Qi, L., Nett, T. M., Allen, M. C., Sha, X., Harrison, G. S., Frederick, B. A., Crawford, E. D., Glode, L. M. (2004). Binding and Cytotoxicity of Conjugated and Recombinant Fusion Proteins Targeted to the Gonadotropin-Releasing Hormone Receptor. Cancer Res. 64: 2090-2095 [Abstract] [Full Text]
Yang, W.-H., Wieczorck, M., Allen, M. C., Nett, T. M. (2003). Cytotoxic Activity of Gonadotropin-Releasing Hormone (GnRH)-Pokeweed Antiviral Protein Conjugates in Cell Lines Expressing GnRH Receptors. Endocrinology 144: 1456-1463 [Abstract] [Full Text]
Narla, R. K., Dong, Y., D’Cruz, O. J., Navara, C., Uckun, F. M. (2000). Bis(4,7-dimethyl-1,10-phenanthroline) Sulfatooxovanadium(IV) as a Novel Apoptosis-inducing Anticancer Agent. Clin. Cancer Res. 6: 1546-1556 [Abstract] [Full Text]
Uckun, F. M., Messinger, Y., Chen, C.-L., O'Neill, K., Myers, D. E., Goldman, F., Hurvitz, C., Casper, J. T., Levine, A. (1999). Treatment of Therapy-Refractory B-Lineage Acute Lymphoblastic Leukemia with an Apoptosis-inducing CD19-directed Tyrosine Kinase Inhibitor. Clin. Cancer Res. 5: 3906-3913 [Abstract] [Full Text]
Sudbeck, E. A., Liu, X.-P., Narla, R. K., Mahajan, S., Ghosh, S., Mao, C., Uckun, F. M. (1999). Structure-based Design of Specific Inhibitors of Janus Kinase 3 as Apoptosis-inducing Antileukemic Agents. Clin. Cancer Res. 5: 1569-1582 [Abstract] [Full Text]
Nishigaki, H., Ito, C., Manabe, A., Kumagai, M.-a., Coustan-Smith, E., Yanishevski, Y., Behm, F. G., Raimondi, S. C., Pui, C.-H., Campana, D. (1997). Prevalence and Growth Characteristics of Malignant Stem Cells in B-Lineage Acute Lymphoblastic Leukemia. Blood 89: 3735-3744 [Abstract] [Full Text]
Uckun, F., Evans, W., Forsyth, C., Waddick, K., Ahlgren, L., Chelstrom, L., Burkhardt, A, Bolen, J, Myers, D. (1995). Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases. Science 267: 886-891 [Abstract]